Apple partners with neurotechnology startup Synchron to integrate the Stentrode implant into its Switch Control accessibility framework, enabling direct device control via neural signals in a semi-invasive brain-computer interface.
Key points
- Apple extends its Switch Control framework to support Synchron’s implantable Stentrode BCI.
- Synchron’s Stentrode uses endovascular electrodes to capture cortical signals for device control.
- Meta’s Brain2Qwerty non-invasive model decodes EEG/MEG signals with 19% character error rate.
Why it matters: Integrating BCI into mainstream devices democratizes access for motor-impaired users and accelerates broader adoption of neural interfaces across industries.
Q&A
- What is a brain-computer interface?
- How does the Stentrode implant work?
- What improvements does Apple’s Switch Control bring?
- What distinguishes invasive and non-invasive BCIs?
- What are the main applications of BCI technology?
